Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

DNTH

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DNTH
DateHeureSourceTitreSymboleSociété
12/06/202413h00GlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
30/05/202422h30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
09/05/202422h01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
08/05/202422h30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
03/05/202422h30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
11/04/202413h30GlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
21/03/202421h01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
07/03/202422h30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
26/02/202413h00GlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DNTH